logo

FBIOP

Fortress Biotech Pref AยทNASDAQ
--
--(--)
--
--(--)

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About FBIOP

Fortress Biotech, Inc.

--
06/28/2006
11/14/2017
NASDAQ Stock Exchange
101
12-31
Preferred stock
1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL 33154
--
Fortress Biotech, Inc., was incorporated in Delaware on June 28, 2006. The company is a biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product income, equity holdings, and dividend and royalty income streams.

Company Financials

EPS

FBIOP has released its 2025 Q3 earnings. EPS was reported at 0.11, versus the expected -0.42, beating expectations. The chart below visualizes how FBIOP has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

FBIOP has released its 2025 Q3 earnings report, with revenue of 17.63M, reflecting a YoY change of 20.52%, and net profit of 8.83M, showing a YoY change of 133.07%. The Sankey diagram below clearly presents FBIOP's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

No Data

You can ask Aime

No Data